# CRyoAblation vs AntiaRrhythmic Drugs for Persistent Atrial Fibrillation Trial

> **NCT03716934** · PHASE4 · COMPLETED · sponsor: **Hospital San Carlos, Madrid** · enrollment: 196 (actual)

## Conditions studied

- Atrial Fibrillation

## Interventions

- **DEVICE:** Arctic Front Advance® balloon catheter
- **DRUG:** Antiarrhythmic drug
- **DEVICE:** Confirm RX heart monitor® (Abbott)

## Key facts

- **NCT ID:** NCT03716934
- **Lead sponsor:** Hospital San Carlos, Madrid
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2018-06-27
- **Primary completion:** 2022-04-18
- **Final completion:** 2022-04-18
- **Target enrollment:** 196 (ACTUAL)
- **Last updated:** 2025-09-15


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03716934

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03716934, "CRyoAblation vs AntiaRrhythmic Drugs for Persistent Atrial Fibrillation Trial". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT03716934. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*